Prime Genomics, Inc.
Biotechnology company · San Francisco, California, United States
Prime Genomics, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2011. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $300,000 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $803,600 sold in a notice filed in 2014.
Prime Genomics at a glance
What does Prime Genomics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $300,000 in total (2019). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $803,600 sold (2014).
Frequently asked questions about Prime Genomics
Where is Prime Genomics headquartered?
Prime Genomics, Inc. is headquartered in San Francisco, California, United States.
What does Prime Genomics do?
Prime Genomics, Inc. is a biotechnology company.
When was Prime Genomics founded?
The earliest incorporation on record for Prime Genomics, Inc. is in 2011, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences